A novel sustained-release formulation of insulin with dramatic reduction in initial rapid release.

[1]  T. Haak,et al.  New developments in the treatment of type 1 diabetes mellitus. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[2]  J L Cleland,et al.  Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[3]  H. Takeuchi,et al.  Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[4]  M. Morishita,et al.  Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats. , 1999, International journal of pharmaceutics.

[5]  Y. Shechter,et al.  New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin. , 1999, Diabetes.

[6]  M. Morishita,et al.  Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. , 1999, Drug development and industrial pharmacy.

[7]  Y. Ogawa,et al.  Utilization of an Amorphous Form of a Water-Soluble GPIIb/IIIa Antagonist for Controlled Release from Biodegradable Microspheres , 1997, Pharmaceutical Research.

[8]  J. Cleland,et al.  The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres , 1997, Pharmaceutical Research.

[9]  A. Shahzamani,et al.  In vivo characterization of sustained-release formulations of human growth hormone. , 1997, The Journal of pharmacology and experimental therapeutics.

[10]  Y. Ogawa,et al.  Sustained release of a water-soluble GP IIb/IIIa antagonist from copoly(dl-lactic/glycolic)acid microspheres , 1997 .

[11]  A. Shahzamani,et al.  A month–long effect from a single injection of microencapsulated human growth hormone , 1996, Nature Medicine.

[12]  S. Kamei,et al.  In vitro release test system of (d,l-lactic-glycolic) acid copolymer microcapsules for sustained release of LHRH agonist (leuprorelin) , 1996 .

[13]  Y. Ogawa,et al.  Application of a spray drying technique in the production of TRH-containing injectable sustained-release microparticles of biodegradable polymers. , 1995, PDA journal of pharmaceutical science and technology.

[14]  H. Okada,et al.  Antitumor Effect of Arterial Administration of a Medium-Chain Triglyceride Solution of an Angiogenesis Inhibitor, TNP-470, in Rabbits Bearing VX-2 Carcinoma , 1995, Pharmaceutical Research.

[15]  T Yashiki,et al.  A new technique to efficiently entrap leuprolide acetate into microcapsules of polylactic acid or copoly(lactic/glycolic) acid. , 1988, Chemical & pharmaceutical bulletin.

[16]  M. Goosen,et al.  Long-acting Insulin: Slow Release of Insulin from a Biodegradable Matrix Implanted in Diabetic Rats , 1983, Diabetes.

[17]  M. Goosen,et al.  Slow release of insulin from a biodegradable matrix implanted in diabetic rats. , 1983, Diabetes.

[18]  J. Parsons,et al.  Prolonged Hypoglycemic Effect in Diabetic Dogs Due to Subcutaneous Administration of Insulin in Liposomes , 1982, Diabetes.

[19]  L. Mandarino,et al.  Dose-response characteristics for effects of insulin on production and utilization of glucose in man. , 1981, The American journal of physiology.

[20]  R. Langer,et al.  One Month of Sustained Release of Insulin from a Polymer Implant , 1980, Diabetes.

[21]  R. Langer,et al.  Polymers for the sustained release of proteins and other macromolecules , 1976, Nature.

[22]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[23]  T. Arakawa,et al.  Some Factors Associated with the Ultrasonic Nebulization of Proteins , 2004, Pharmaceutical Research.

[24]  H. Okada,et al.  Preparation of Three-Month Depot Injectable Microspheres of Leuprorelin Acetate Using Biodegradable Polymers , 2004, Pharmaceutical Research.

[25]  M A Tracy,et al.  Development and Scale‐up of a Microsphere Protein Delivery System , 1998, Biotechnology progress.

[26]  Y. Ogawa.  Injectable microcapsules prepared with biodegradable poly(alpha-hydroxy) acids for prolonged release of drugs. , 1997, Journal of biomaterials science. Polymer edition.

[27]  L. T. Ho,et al.  Insulin controlled-release microcapsules to prolong the hypoglycemic effect in diabetic rats. , 1988, Biomaterials, artificial cells, and artificial organs.